No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs201949063 |
chr9:141041286-141041287 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs554488987 |
chr9:141041353-141041354 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs113319107 |
chr9:141041409-141041410 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs368415475 |
chr9:141041464-141041465 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs371433213 |
chr9:141041498-141041499 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs2507150 |
chr9:141041528-141041529 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs369403120 |
chr9:141041597-141041598 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs201494169 |
chr9:141041659-141041660 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs539849312 |
chr9:141041680-141041681 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs572694508 |
chr9:141041732-141041733 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs371229497 |
chr9:141041733-141041734 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs573961495 |
chr9:141041761-141041762 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs543328305 |
chr9:141041764-141041765 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs2507149 |
chr9:141041956-141041957 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs559643696 |
chr9:141041983-141041984 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs112284895 |
chr9:141041987-141041988 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs556154643 |
chr9:141042030-141042031 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs150098581 |
chr9:141042052-141042053 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs138372924 |
chr9:141042060-141042061 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
20 |
rs554304719 |
chr9:141042081-141042082 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs574618372 |
chr9:141042086-141042087 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs112113487 |
chr9:141042120-141042121 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs7855994 |
chr9:141042131-141042132 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
24 |
rs373316145 |
chr9:141042181-141042182 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs530873104 |
chr9:141042187-141042188 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs184709162 |
chr9:141042188-141042189 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
27 |
rs2507148 |
chr9:141042201-141042202 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs75763938 |
chr9:141042224-141042225 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
29 |
rs76947912 |
chr9:141042233-141042234 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
30 |
rs531994310 |
chr9:141042260-141042261 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs536126602 |
chr9:141042263-141042264 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs545779125 |
chr9:141042286-141042287 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs9969703 |
chr9:141042287-141042288 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs562487773 |
chr9:141042317-141042318 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs75461316 |
chr9:141042318-141042319 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs2507147 |
chr9:141042324-141042325 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs76752170 |
chr9:141042331-141042332 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs371411886 |
chr9:141042365-141042366 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs548314203 |
chr9:141042376-141042377 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs113050339 |
chr9:141042394-141042395 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs568550800 |
chr9:141042395-141042396 |
Active TSS Enhancers Bivalent/Poised TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs9410082 |
chr9:141042410-141042411 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs9410083 |
chr9:141042412-141042413 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs117292644 |
chr9:141042470-141042471 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs9410171 |
chr9:141042489-141042490 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs55950355 |
chr9:141042492-141042493 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
47 |
rs71510897 |
chr9:141042531-141042532 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs569725993 |
chr9:141042565-141042566 |
Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs71485043 |
chr9:141042644-141042645 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs74880991 |
chr9:141042685-141042686 |
Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|